GlaxoSmithKline and Sirna Enter Major RNAi Collaboration

By Business Review Editor

Pharma Deals Review: Vol 2006 Issue 71 (Table of Contents)

Published: 6 May-2006

DOI: 10.3833/pdr.v2006.i71.515     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

Global giant GlaxoSmithKline has entered into a multiyear collaboration with Sirna Therapeutics to develop novel RNAi-based therapeutics for respiratory diseases...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details